Athanase Innovation AB (ATIN) Stock Statistics & Valuation Metrics

Athanase Innovation AB has a market cap or net worth of kr347.36M. The enterprise value is kr130.47M.

Athanase Innovation AB has 19,297,642 shares outstanding. The number of shares has decreased by -2.65% in one year.

Athanase Innovation AB’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is -4.89%.

The current PE Ratio of Athanase Innovation AB is ―. Athanase Innovation AB’s PEG ratio is 0.44.

In the last 12 months, Athanase Innovation AB had revenue of 176.83M and earned -19.64M in profits. Earnings per share was -0.83.

In the last 12 months, operating cash flow was -57.46M and capital expenditures 14.79M, giving a free cash flow of -41.18M billion.

Athanase Innovation AB pays an annual dividend of kr289.504, resulting in a dividend yield of ―

Athanase Innovation AB upcoming earnings date is Feb 20, 2026, Before Open (Confirmed).

Athanase Innovation AB as a current ratio of 5.12, with Debt / Equity ratio of 0.00%

In the past 12 months, Athanase Innovation AB has paid -4.00K in taxes.

Athanase Innovation AB EV to EBITDA ratio is 243.17, with an EV/FCF ratio of -11.32.

Athanase Innovation AB has kr255.49M in cash and marketable securities with kr0.00 in debt, giving a net cash position of kr255.49M billion.

Gross margin is 9.35%, with operating margin of -13.40%, and net profit margin of -11.11%.

The average price target for Athanase Innovation AB is ―, which is 11.43% higher than the current price. The consensus rating is ―